JESSICA SHEPPARD: Open Payments
NPI 1609322197 · SNELLVILLE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,218 in 32 payments from 12 companies in 2025. Trend: 2023 $2,787 · 2024 $2,569 · 2025 $1,218
Food & beverage: $1,218
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. | 16 | $728 |
| Dendreon Pharmaceuticals LLC | 2 | $146 |
| Janssen Biotech, Inc. | 2 | $68 |
| Sumitomo Pharma America, Inc. | 3 | $62 |
| Merck Sharp & Dohme LLC | 2 | $58 |
| Caris MPI, Inc. | 1 | $34 |
| ABBVIE INC. | 1 | $25 |
| Tempus AI, Inc | 1 | $23 |
| AstraZeneca Pharmaceuticals LP | 1 | $20 |
| Teleflex LLC | 1 | $19 |
Products named: INTERSTIM, PROVENGE, ERLEADA, LYNPARZA, KEYTRUDA, MI CANCER SEEK, GEMTESA, ORGOVYX.
Industry payments across GA — which companies pay providers there.
